Back to search results

Dupuytren Contracture Surgery and Scarring Study

This study is looking at ways to reduce scarring and other problems after surgery for Dupuytren contracture (a condition where tissue under the skin of your palm thickens, causing fingers to bend). If you have trigger finger with a thickened cord from Dupuytren contracture and are having surgery, you might be able to join. Researchers are comparing two surgical methods: one where the cord is cut and removed (pretendinous cord excision) and another where it's only cut (division/manipulation of the cord). The goal is to see if removing the cord leads to less scarring, measured by special scales for up to one year after surgery. This research aims to improve surgical outcomes and patient experience.

Study design
This interventional study plans to enroll 50 participants. It is not specified if it is randomized or blinded.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your scar progression will be measured at the start of the study and for up to one year after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03155854

The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring

Recruiting
NAAges 18+InterventionalTreatment
Mayo Clinic
~50 participants
Updated 2026-03-16 on ClinicalTrials.gov
What's tested:Pretendinous cord excisionDivision/manipulation of the cord

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Scar Progression as measured by the Vancouver Scar Scale
Measured over baseline, up to 1 year
+1 more outcome measured

Conditions

Dupuytren Contracture

Explore related trials

Acquired trigger fingerPalmar Fibromatosis

Where it's being run

1 sites across 1 states
Minnesota1

Study leadership

  • Sanjeev Kakar, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

Sanjeev Kakar, MD
[email protected]
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Potential candidates for the study will be selected based upon clinical diagnosis of trigger finger with co-existing pretendinous cord. All potential subjects will have either failed non operative treatment or elected surgical treatment.

Exclusion

\<18 years of age

What this trial measures

  • Change in Scar Progression as measured by the Vancouver Scar Scalebaseline, up to 1 year

    The Vancouver Scar Scale assesses 4 variables: vascularity, height/thickness, pliability, and pigmentation. Patient perception of his or her respective scars is not factored in to the overall score. The scores can range from 0 (normal) to 13 (severe scarring).

  • Change in Scar Progression as measured by the Patient and Observer Scar Assessment Scalebaseline, up to 1 year

    The Patient and Observer Scar Assessment Scale consists of two parts: a Patient Scale and an Observer Scale. Both scales contain seven items that are scored numerically on a 10-step scale. Together they make up the 'Total Score' of the Patient and Observer Scale. The total score can range from 14 (normal) to 140 (worst scar imaginable).